Drug intelligence / Profile preview

Goenback sesame extract

Development stage
Unknown
Lead developer
HL Science
Modality
Small Molecules
Administration
Oral
01

Overview

Goenback sesame extract, also known by the research code HL-JOINT 100, is a proprietary botanical extract derived from sesame seeds (*Sesamum indicum*) and developed by the South Korean company HL Science. Standardized to high concentrations of the lignans sesamin and sesamolin, the extract is primarily indicated for the maintenance of joint and cartilage health. Its mechanism of action involves the down-regulation of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), as well as the inhibition of matrix metalloproteinases (MMPs) such as MMP-1, MMP-3, and MMP-13, which are responsible for cartilage degradation. Clinical studies have demonstrated its ability to improve joint function and reduce pain scores in patients with osteoarthritis. In 2018, it received recognition from the South Korean Ministry of Food and Drug Safety (MFDS) as a functional health food ingredient for joint and cartilage health.

Brand names
Goenback
Other names
Sesame seed extractSesamum indicum extract
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL-6 (Interleukin 6)MMP1 (Matrix metalloproteinase-1)MMP13 (Matrix metalloproteinase-13)MMP3 (Matrix metalloproteinase-3)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Goenback sesame extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goenback sesame extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call